+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 1
Age: 18Years - 74Years
All Genders
ID07431112

Phase 1 Study Evaluating Safety and Effects of Subcutaneous AIR-001 in Adults with Alpha-1 Antitrypsin Deficiency Due to PiZZ Genotype

Led by AIRNA Corporation · Updated on 2026-10-23

54

Participants Needed

13

Research Sites

8 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying AIR-001, an RNA-editing oligonucleotide, in adults with alpha-1 antitrypsin deficiency AATD due to the PiZZ genotype. This Phase 1, open-label trial aims to evaluate the safety, tolerability, pharmacokinetics PK, and pharmacodynamics PD of AIR-001 given by subcutaneous injection. The study focuses on participants with specific genetic and clinical characteristics related to AATD. Participants receive AIR-001 either as single ascending doses or multiple doses administered by subcutaneous injection. The study includes several cohorts receiving different dose levels of AIR-001. Treatment periods vary depending on whether participants are in the single dose or multiple dose groups, with all doses given under medical supervision. There is no placebo group, and the study follows a sequential design. During the trial, participants will be closely monitored for treatment-emergent adverse events, laboratory abnormalities, vital signs, and electrocardiogram changes up to 169 days after dosing. Evaluations include measurements of AIR-001 concentration in plasma and changes in serum alpha-1 antitrypsin protein levels. Participants must consent to study procedures and comply with the schedule, which includes safety and laboratory assessments throughout the study period, lasting approximately up to five and a half months after dosing.

CONDITIONS

Brief Title

A Study of AIR-001 in Adults With Alpha-1 Antitrypsin Deficiency (AATD)

Research Team

A

AIRNA Corporation Clinical Trials Information

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here